Nanoviricides (NNVC) Retained Earnings (2011 - 2026)
Nanoviricides (NNVC) recorded Retained Earnings of -$157.1 million in fiscal Q4 2026 (quarter ended Jun 30, 2026), compared with -$148.84 million a year earlier.
Powered by 
Analysis
Nanoviricides (NNVC) Retained Earnings (2011 - 2026) Analysis & Trends
Starting with fiscal Q4 2011, Nanoviricides' Retained Earnings history includes 61 quarters.
- Across earlier fiscal years, Retained Earnings came in at -$148.84 million in FY2025, -$139.37 million in FY2024, -$131.08 million in FY2023 and -$122.49 million in FY2022.
- The fiscal Q4 2026 figure is the lowest quarterly Retained Earnings in data going back to fiscal Q4 2011.
- Per Business Quant, the preceding three fiscal quarters came in at -$154.84 million (Q3 2026), -$152.85 million (Q2 2026) and -$150.63 million (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 31.89 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 171.67 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | -17.33 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | 63.27 Bn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 12.59 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | -22.28 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | 2.20 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 112.09 Bn |
| 10 | Nanoviricides | 30.08 Mn | 17.74 Mn | - | -157.10 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -157.10 Mn |
| Mar 31, 2026 | -154.84 Mn |
| Dec 31, 2025 | -152.85 Mn |
| Sep 30, 2025 | -150.63 Mn |
| Jun 30, 2025 | -148.84 Mn |
| Mar 31, 2025 | -146.75 Mn |
| Dec 31, 2024 | -144.53 Mn |
| Sep 30, 2024 | -142.50 Mn |
| Jun 30, 2024 | -139.37 Mn |
| Mar 31, 2024 | -137.02 Mn |
| Dec 31, 2023 | -135.16 Mn |
| Sep 30, 2023 | -133.05 Mn |
| Jun 30, 2023 | -131.08 Mn |
| Mar 31, 2023 | -127.51 Mn |
| Dec 31, 2022 | -126.00 Mn |
| Sep 30, 2022 | -124.06 Mn |
| Jun 30, 2022 | -122.49 Mn |
| Mar 31, 2022 | -121.00 Mn |
| Dec 31, 2021 | -119.00 Mn |
| Sep 30, 2021 | -117.00 Mn |
API Access
Nanoviricides Retained Earnings API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=retained-earnings&ticker=NNVC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "retained-earnings", "ticker": "NNVC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=retained-earnings&ticker=NNVC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();